Does ENZALUTAMIDE Cause Rash generalised? 106 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Rash generalised have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
106
Reports of Rash generalised with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
5
Deaths
18
Hospitalizations
How Dangerous Is Rash generalised From ENZALUTAMIDE?
Of the 106 reports, 5 (4.7%) resulted in death, 18 (17.0%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Rash generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Rash generalised?
ADALIMUMAB (704)
ETANERCEPT (498)
LENALIDOMIDE (484)
LAMOTRIGINE (295)
AMOXICILLIN (268)
CERTOLIZUMAB PEGOL (214)
RIBAVIRIN (205)
DENOSUMAB (199)
EVOLOCUMAB (172)
APREMILAST (161)
Which ENZALUTAMIDE Alternatives Have Lower Rash generalised Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE